Abstract:
A therapeutic agent HJ001 isolated from Citrus reticulata Blanco is provided to inhibit growth of cancer cells and reduce expressions of IL-3(interleukin-3), IL-6, IL-12p40p70, IL-12p70 and SCF(stem cell factor) and increase expressions of IL-10 and TNF(tumor necrosis factor), so that it is useful for treatment of cancer and inflammatory disease. A method for preparing the extract of Citrus reticulata Blanco HJ001 comprises the steps of: dipping Citrus reticulata Blanco powder in water and filtering the solution; passing the filtered solution through the column packed with fillers HP-20 and collecting passed solution; mixing the collected solution with water-saturated ethylacetate to transfer it into an ethylacetate layer; inducing layer separation of the mixture into the ethylacetate layer and water layer, and separating the water layer; mixing the water layer with water-saturated butanol and separating a butanol layer; absorbing the butanol layer to TLC(thin layer chromatography) silica; subjecting the TLC silica by using chloroform, methanol and water as development solvent and separating the developed portion; dissolving the developed portion in butanol, and filtering and concentrating the solution; freeze-drying the filtered solution to obtain materials Fr1 and Fr2; and separating the Fr2 from the Fr1 and Fr2.